2008 Annual Report
(PDF - 3.1 MB)
Current Investor Presentation
(PDF - 1.27 MB)
|
 |
News Releases
All Releases
 |
Endologix to Present at the ROTH 22nd Annual OC Growth Stock Conference
Feb 24, 2010
|
9.0 KB |
|
| |
IRVINE, Calif., Feb 24, 2010 /PRNewswire via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at the ROTH 22nd Annual OC Growth Stock Conference at The Ritz-Carlton Hotel in Lag...
|
|
Endologix Reports 28% Fourth Quarter 2009 Revenue Growth and Continued Positive Cash Flow from Operations
Feb 18, 2010
|
16.2 KB |
|
| |
IRVINE, Calif., Feb 18, 2010 /PRNewswire via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, today announced financial results for the three and twelve months ended December 31, 2009.
John McDermott, Endologix President and Chief Executive Officer, said, "The fourth quarter ...
|
|
Endologix to Report Fourth Quarter and Full Year 2009 Financial Results on February 18, 2010
Feb 11, 2010
|
8.7 KB |
|
| |
IRVINE, Calif., Feb 11, 2010 /PRNewswire via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its fourth quarter and full year 2009 financial results, which will take place on Thursday, February 18, 2010 after the close of the...
|
|
Court Grants Endologix's Motion to Stay Patent Litigation
Jan 13, 2010
|
9.7 KB |
|
| |
IRVINE, Calif., Jan 13, 2010 /PRNewswire via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that the United States Patent and Trademark Office (USPTO) has granted both of Endologix's requests for reexamination of the two patents asserted by Cook, Inc. in the l...
|
|
Endologix Appoints Dan Lemaitre to its Board of Directors
Dec 10, 2009
|
9.5 KB |
|
| |
IRVINE, Calif., Dec 10, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that Dan Lemaitre, former President and CEO of CoreValve, has joined the Endologix Board of Directors effective December 11, 2009. Endologix now has four ind...
|
|
Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement
Nov 24, 2009
|
9.6 KB |
|
| |
IRVINE, Calif., Nov 24, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has filed a motion to stay, or discontinue all proceedings in, the patent infringement lawsuit brought against it in October 2009 by Cook, Inc. The m...
|
|
Endologix Receives IDE Approval for Fully Percutaneous Approach to EVAR
Nov 18, 2009
|
11.1 KB |
|
| |
IRVINE, Calif., Nov 18, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has received Investigational Device Exemption (IDE) conditional approval from the United States Food and Drug Administration ("FDA") to begin a prospe...
|
|
Endologix to Present at Three Upcoming Conferences
Nov 3, 2009
|
9.3 KB |
|
| |
IRVINE, Calif., Nov 03, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at three upcoming investor conferences. The first presentation will be at...
|
|
Endologix Reports 47% Third Quarter 2009 Revenue Growth
Oct 27, 2009
|
16.9 KB |
|
| |
IRVINE, Calif., Oct 27, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, today announced financial results for the three and nine months ended September 30, 2009.
John McDermott, Endologix President and Chief Executive Officer, said, "Our strong ...
|
|
Endologix to Report Third Quarter 2009 Financial Results on October 27, 2009
Oct 16, 2009
|
9.7 KB |
|
| |
IRVINE, Calif., Oct 16, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its third quarter 2009 financial results, which will take place on Tuesday, October 27, 2009 after the close of the market....
|
|
Endologix Responds to Alleged Patent Infringement
Oct 13, 2009
|
9.2 KB |
|
| |
IRVINE, Calif., Oct 13, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has conducted further evaluation of the patent infringement lawsuit filed against the company last week by Cook Medical, and of the patents asserted i...
|
|
Endologix Comments on Alleged Patent Infringement
Oct 8, 2009
|
9.2 KB |
|
| |
IRVINE, Calif., Oct 08, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, acknowledged today that it has become aware that Cook Medical has filed a lawsuit against Endologix in the United States District Court alleging that Endologix infringes two ...
|
|
Endologix Announces Publication of Powerlink XL Clinical Trial Results
Aug 20, 2009
|
12.1 KB |
|
| |
IRVINE, Calif., Aug 20, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today the online publication of results from the pivotal prospective, multicenter clinical trial of the Company's Powerlink XL((R)) System for treatment of abdomina...
|
|
Endologix Announces Pricing of Public Offering of Common Stock
Jul 30, 2009
|
10.4 KB |
|
| |
IRVINE, Calif., July 30, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX) today announced that it has entered into an agreement to sell 3,900,000 shares of its common stock in an underwritten public offering at a price to the public of $4.10 per share. The gross proceeds to Endologix, before offering expenses, ...
|
|
Endologix Reports 42% Second Quarter 2009 Revenue Growth
Jul 22, 2009
|
16.1 KB |
|
| |
IRVINE, Calif., July 22, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, today announced financial results for the three months ended June 30, 2009.
"During the second quarter we continued to benefit from our recent new product launches and inve...
|
|
Endologix to Report Second Quarter 2009 Financial Results on July 22, 2009
Jul 9, 2009
|
9.6 KB |
|
| |
IRVINE, Calif., July 9, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its second quarter 2009 financial results, which will take place on Wednesday, July 22, 2009 after the close of the market....
|
|
Endologix Added to Russell Indexes
Jun 30, 2009
|
9.7 KB |
|
| |
IRVINE, Calif., June 30, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, today announced that it has been added to the Russell 3000(R), Russell 2000(R) and Russell Global Indexes, effective June 26, 2009 after the close of the U.S. markets.
John...
|
|
Endologix Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17, 2009 at 4:15 p.m. ET
Jun 15, 2009
|
10.1 KB |
|
| |
IRVINE, Calif., June 15, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, today announced that John McDermott, President and CEO, is scheduled to deliver a presentation to the investment community on Wednesday, June 17, 2009 at 4:15 pm ET as part ...
|
|
Endologix Receives Nasdaq Letter on Director Independence
Jun 12, 2009
|
9.6 KB |
|
| |
IRVINE, Calif., June 12, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, today announced that on June 12, 2009, the Company received written notification from Nasdaq that the Company was no longer in compliance with Marketplace Rule 4350(c), whic...
|
|
Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System
Jun 1, 2009
|
10.8 KB |
|
| |
IRVINE, Calif., June 1, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Endologix, Inc. (Nasdaq: ELGX) today announced the full commercial launch of the InutiTrak(TM) Express Delivery System for the endovascular treatment of large neck abdominal aortic aneurysms (AAA). The IntuiTrak family of devices features low profile, minimally invasive ...
|
|
|
= add release to Briefcase |
Home | 
Contact Us 
